Deconstruction of the SS18-SSX fusion oncoprotein complex: insights into disease etiology and therapeutics.

[1]  C. Shaffer,et al.  Reprogramming of mesenchymal stem cells by the synovial sarcoma-associated oncogene SYT–SSX2 , 2012, Oncogene.

[2]  M. Wick,et al.  Immunohistochemical staining for TLE1 distinguishes synovial sarcoma from histologic mimics. , 2011, American journal of clinical pathology.

[3]  Teruhiko Yoshida,et al.  Gene Expression Profiling of Synovial Sarcoma: Distinct Signature of Poorly Differentiated Type , 2010, The American journal of surgical pathology.

[4]  T. Nielsen,et al.  EGR1 reactivation by histone deacetylase inhibitors promotes synovial sarcoma cell death through the PTEN tumor suppressor , 2010, Oncogene.

[5]  T. Nielsen,et al.  Small blue round cell tumor of the interosseous membrane bearing a t(2;22)(q34;q12)/EWS-CREB1 translocation: a case report , 2010, Molecular Cytogenetics.

[6]  Z. Ronai,et al.  Emerging roles of ATF2 and the dynamic AP1 network in cancer , 2010, Nature Reviews Cancer.

[7]  I. Petersen,et al.  TLE1 is a robust diagnostic biomarker for synovial sarcomas and correlates with t(X;18): analysis of 319 cases. , 2010, European journal of cancer.

[8]  S. K. Zaidi,et al.  Transcriptional corepressor TLE1 functions with Runx2 in epigenetic repression of ribosomal RNA genes , 2010, Proceedings of the National Academy of Sciences.

[9]  Raymond R Tubbs,et al.  Prospective Evaluation of TLE1 as a Diagnostic Immunohistochemical Marker in Synovial Sarcoma , 2009, The American journal of surgical pathology.

[10]  Patrick J. Boyle,et al.  The BTB/POZ Domain of the Arabidopsis Disease Resistance Protein NPR1 Interacts with the Repression Domain of TGA2 to Negate Its Function[W] , 2009, The Plant Cell Online.

[11]  A. Folpe,et al.  TLE1 expression is not specific for synovial sarcoma: a whole section study of 163 soft tissue and bone neoplasms , 2009, Modern Pathology.

[12]  R. Molday,et al.  A carboxy-terminal affinity tag for the purification and mass spectrometric characterization of integral membrane proteins. , 2009, Journal of proteome research.

[13]  Tsutomu Ohta,et al.  PH Domain-Only Protein PHLDA3 Is a p53-Regulated Repressor of Akt , 2009, Cell.

[14]  M. Capecchi,et al.  Synovial Sarcoma: From Genetics to Genetic-based Animal Modeling , 2008, Clinical orthopaedics and related research.

[15]  T. Nielsen,et al.  Histone deacetylase inhibitors induce growth arrest, apoptosis, and differentiation in clear cell sarcoma models , 2008, Molecular Cancer Therapeutics.

[16]  J. Licht,et al.  ATF-2 controls transcription of Maspin and GADD45α genes independently from p53 to suppress mammary tumors , 2008, Oncogene.

[17]  P. Meltzer,et al.  Suppressor role of activating transcription factor 2 (ATF2) in skin cancer , 2008, Proceedings of the National Academy of Sciences.

[18]  M. Rijn,et al.  in Synovial Sarcoma Response 1 Early Growth Polycomb Silencing of the Tumor Suppressor Mediated − Histone Deacetylase Inhibitors Reverse SS 18-SSX , 2008 .

[19]  R. Sears,et al.  CIP2A Inhibits PP2A in Human Malignancies , 2007, Cell.

[20]  Malay Haldar,et al.  A conditional mouse model of synovial sarcoma: insights into a myogenic origin. , 2007, Cancer cell.

[21]  Marc Ladanyi,et al.  TLE1 as a Diagnostic Immunohistochemical Marker for Synovial Sarcoma Emerging From Gene Expression Profiling Studies , 2007, The American journal of surgical pathology.

[22]  Koichi Nagasaki,et al.  Reduced Levels of ATF-2 Predispose Mice to Mammary Tumors , 2006, Molecular and Cellular Biology.

[23]  M. Ohki,et al.  The SYT-SSX Fusion Protein Down-Regulates the Cell Proliferation Regulator COM1 in t(x;18) Synovial Sarcoma , 2006, Molecular and Cellular Biology.

[24]  R. Kobayashi,et al.  CUL4–DDB1 ubiquitin ligase interacts with multiple WD40-repeat proteins and regulates histone methylation , 2006, Nature Cell Biology.

[25]  P. Meltzer,et al.  The synovial-sarcoma-associated SS18-SSX2 fusion protein induces epigenetic gene (de)regulation. , 2006, Cancer research.

[26]  Jian Jian Li,et al.  Mutual regulation of c‐Jun and ATF2 by transcriptional activation and subcellular localization , 2006, The EMBO journal.

[27]  P. Meltzer,et al.  Gene expression profiling of human sarcomas: insights into sarcoma biology. , 2005, Cancer research.

[28]  H. Inoue,et al.  Significant growth suppression of synovial sarcomas by the histone deacetylase inhibitor FK228 in vitro and in vivo. , 2005, Cancer letters.

[29]  A. Mancini,et al.  Early Growth Response Factor-1 Mediates Prostaglandin E2-dependent Transcriptional Suppression of Cytokine-induced Tumor Necrosis Factor-α Gene Expression in Human Macrophages and Rheumatoid Arthritis-affected Synovial Fibroblasts* , 2005, Journal of Biological Chemistry.

[30]  Michael McClelland,et al.  Identification of promoters bound by c-Jun/ATF2 during rapid large-scale gene activation following genotoxic stress. , 2004, Molecular cell.

[31]  R. Halaban,et al.  Subcellular localization of activating transcription factor 2 in melanoma specimens predicts patient survival. , 2003, Cancer research.

[32]  Brigitte Wild,et al.  Histone Methyltransferase Activity of a Drosophila Polycomb Group Repressor Complex , 2002, Cell.

[33]  Hengbin Wang,et al.  Role of Histone H3 Lysine 27 Methylation in Polycomb-Group Silencing , 2002, Science.

[34]  D. Botstein,et al.  For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group , 2022 .

[35]  J. Yokota,et al.  Infrequent mutations of the activating transcription factor-2 gene in human lung cancer, neuroblastoma and breast cancer. , 2002, International journal of oncology.

[36]  L. Olson,et al.  Temporal regulation of a paired-like homeodomain repressor/TLE corepressor complex and a related activator is required for pituitary organogenesis. , 2001, Genes & development.

[37]  M. Ladanyi.  Fusions of the SYT and SSX genes in synovial sarcoma , 2001, Oncogene.

[38]  H. Sonobe,et al.  Analysis of transforming activity of human synovial sarcoma-associated chimeric protein SYT-SSX1 bound to chromatin remodeling factor hBRM/hSNF2α , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[39]  Y. Nakatani,et al.  ATF-2 has intrinsic histone acetyltransferase activity which is modulated by phosphorylation , 2000, Nature.

[40]  J. Fernández,et al.  A functional interaction between the histone deacetylase Rpd3 and the corepressor groucho in Drosophila development. , 1999, Genes & development.

[41]  P. Freemont,et al.  SSX and the synovial-sarcoma-specific chimaeric protein SYT-SSX co-localize with the human Polycomb group complex , 1999, Oncogene.

[42]  D. Brett,et al.  Functional domains of the SYT and SYT-SSX synovial sarcoma translocation proteins and co-localization with the SNF protein BRM in the nucleus. , 1999, Human molecular genetics.

[43]  F. Lim,et al.  A KRAB-related domain and a novel transcription repression domain in proteins encoded by SSX genes that are disrupted in human sarcomas , 1998, Oncogene.

[44]  A. Podtelejnikov,et al.  Linking genome and proteome by mass spectrometry: large-scale identification of yeast proteins from two dimensional gels. , 1996, Proceedings of the National Academy of Sciences of the United States of America.